Tandem Diabetes Care Inc (TNDM) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally.
Total Assets Chart for Tandem Diabetes Care Inc
Tandem Diabetes Care Inc (TNDM) total assets for FY2025 were USD 881.1M, a -8.9% change from FY2024. Tandem Diabetes Care Inc's total assets grew from USD 14.0M in 2011 to USD 881.1M in 2025 (6203.7% over 14 years). Total assets compound annual growth rate: 5-year CAGR of 4.2%, 10-year CAGR of 21.6%.
Total Assets (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $1.21B
- Implied Share Price
- $17.43
- Enterprise Value
- $1.02B
- Revenue (TTM)
- $1.04B
- EBITDA
- -$25.03M
- Profit Margin
- -6.08%
- Trailing P/E
- —
- Forward P/E
- 1111.11
- Price/Book (MRQ)
- 6.65
- Price/Sales (TTM)
- 1.16
- EV/EBITDA
- 345.75
- EV/Revenue
- 1.02
- Dividend Yield
- —
- Book Value
- $1.88
- Free Cash Flow (FY2025)
- -$29.67M
- Free Cash Flow Yield
- -2.45%
Snapshot as of 24th October 2026 — not point-in-time controlled, may lag the live market by a few days.